Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Market Cap
94583676
Market Cap Growth
242.32%-13.25%-38.41%-77.68%-51.75%1038.67%
Enterprise Value
8.354.332.945.358.9868.6
Last Close Price
1.266.6922.92258.461491.6912652.30

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
3.41233.5733.9323.2775.42-
PB Ratio
--8.96-22.19-3.211.6425.03

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
EV/Sales Ratio
8.35232.5719.9215.2718.57-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Debt / Equity Ratio
-0.02-0.27-0.90-0.100.010.12
Asset Turnover
-0.000.030.020.030
Quick Ratio
0.180.280.550.464.121.56
Current Ratio
0.260.660.860.664.301.62
Return on Equity (ROE)
-3053.85%2089.93%1362.37%-301.42%-197.66%36739.16%
Return on Assets (ROA)
-326.04%-288.99%-333.81%-170.40%-135.65%-122.64%
Return on Invested Capital (ROIC)
-2232.90%-1558.83%-2651.49%-4153.91%-2860.72%-117.51%
Return on Capital Employed (ROCE)
-2970.96%4435.65%1546.77%-297.35%-196.30%-290.15%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Buyback Yield / Dilution
-469.85%-404.96%-425.71%-147.76%-160.57%-3409.64%
Total Shareholder Return
-469.85%-404.96%-425.71%-147.76%-160.57%-3409.64%
SEC Filings: 10-K · 10-Q